Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)
China flag China · Delayed Price · Currency is CNY
38.96
-0.04 (-0.10%)
Sep 10, 2026, 3:00 PM CST

SHA:603139 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-284.16-333.45-89.63-26.16-63.0636.48
Depreciation & Amortization
71.2565.8659.8937.7125.3416.37
Other Amortization
1.281.441.091.016.460.43
Loss (Gain) From Sale of Assets
-42.490.31-0.66-0.10.02-
Asset Writedown & Restructuring Costs
163.8165.341.216.911.530.01
Loss (Gain) From Sale of Investments
4.728.3331.1528.7454.83-23.44
Provision & Write-off of Bad Debts
13.2716.445.920.838.781.71
Other Operating Activities
77.4365.6429.375.734.6612.47
Change in Accounts Receivable
-22.3-24.0524.45-82.39-26.841.25
Change in Inventory
-127.738.29-9.8728.45-7.09-9.22
Change in Accounts Payable
165.1619.35-1.93-65.2944.77-26.99
Change in Other Net Operating Assets
-0.13-0.040.26-4.82--
Operating Cash Flow
10.64-16.7237.29-72.1350.437.42
Operating Cash Flow Growth
-69.19%---579.82%-92.08%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-127.35-15.53-46.66-72.38-138.13-290.3
Sale of Property, Plant & Equipment
115.320.196.510.320.140.08
Cash Acquisitions
1.491.49-3.0125.34--8.26
Divestitures
5.385.38-0.98--
Investment in Securities
-15.41-9.8326.02-0.5587.42-97.38
Other Investing Activities
-0.69-0.620.337.1716.89
Investing Cash Flow
-21.26-18.3-16.52-45.97-43.4-378.98

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-3.93.623.1311.731.93
Long-Term Debt Issued
-326.05341.12322.65231.36476.9
Total Debt Issued
155.59329.95344.74325.78243.1478.83
Short-Term Debt Repaid
--2.54-8.9-2.05-0.79-2.77
Long-Term Debt Repaid
--270.31-375.61-235.23-205.62-65.39
Lease Payments
-0.53-0.53-1.53-0.24--
Total Debt Repaid
-323.08-272.85-384.52-237.28-206.41-68.16
Net Debt Issued (Repaid)
-167.557.1-39.7888.4936.68410.67
Issuance of Common Stock
48.77-----
Common Dividends Paid
-25.15-27.86-28.93-30.73-32.26-33.38
Other Financing Activities
102.37-42.71-3.123.171.02
Financing Cash Flow
-41.525.24-65.9954.657.59378.31

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-52.13-9.78-45.22-63.4514.636.75

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-116.71-32.25-9.37-144.52-87.7-282.88
Free Cash Flow Growth
------
Free Cash Flow Margin
-27.20%-6.84%-1.67%-21.48%-17.84%-63.89%
Free Cash Flow Per Share
-1.17-0.32-0.09-1.44-0.88-2.87
Levered Free Cash Flow
471.55165.85-20.57-123.73-141.29-237.69
Unlevered Free Cash Flow
493.14187.311.17-109.07-133.02-233.74
Free Cash Flow After Leases
-117.24-32.78-10.89-144.76-87.7-282.88

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
12.7429.1342.6431.71-12.1118.01
Change in Working Capital
5.54-6.63-1.04-136.811.87-36.62